Short term, low dose alpha-ketoglutarate based polymeric nanoparticles with methotrexate reverse rheumatoid arthritis symptoms in mice and modulate T helper cell responses

Biomater Sci. 2022 Nov 22;10(23):6688-6697. doi: 10.1039/d2bm00415a.

Abstract

Activated effector T cells induce pro-inflammatory responses in rheumatoid arthritis (RA) which then lead to inflammation of the joints. In this report, we demonstrate that polymeric nanoparticles with alpha keto-glutarate (aKG) in their polymer backbone (termed as paKG NPs) modulate T cell responses in vitro and in vivo. Impressively, a low dose of only three administrations of methotrexate, a clinically and chronically administered drug for RA, in conjunction with two doses of paKG NPs, reversed arthritis symptoms in collagen-induced arthritis (CIA) mice. This was further followed by significant decreases in pro-inflammatory antigen-specific T helper type 17 (TH17) responses and a significant increase in anti-inflammatory regulatory T cell (TREG) responses when CIA treated splenic cells were isolated and re-exposed to the CIA self-antigen. Overall, this study supports the concurrent and short term, low dose of paKG NPs and methotrexate for the reversal of RA symptoms.

MeSH terms

  • Animals
  • Arthritis, Experimental* / chemically induced
  • Arthritis, Experimental* / drug therapy
  • Arthritis, Rheumatoid* / drug therapy
  • Ketoglutaric Acids / therapeutic use
  • Methotrexate / pharmacology
  • Methotrexate / therapeutic use
  • Mice
  • Mice, Inbred DBA
  • Nanoparticles*
  • Polymers / therapeutic use
  • T-Lymphocytes, Helper-Inducer / metabolism

Substances

  • Methotrexate
  • Ketoglutaric Acids
  • Polymers